Developing Blood-Based Biomarkers to Stratify Alzheimer’s Patients & Deploy Improved Neurodegenerative Treatments using Exploratory Biomarker Panels
Time: 11:30 am
day: Day 1 AM
Details:
- Using blood based biomarker to understand the pathological processes in the brain
- Validation of assays making them fit for the intended purpose
- Understanding the ability of staging patients based on biomarkers and not imaging or scoring tests
- Establishing multi-institutional and cross-sector collaboration to accelerate the clinical adoption of blood-based biomarkers for Alzheimer’s
